which of these ideas has the most impact? let Opus generate Idea and others should refine it an score it. do that for a total of 10 ideas. MRI images frequently suffer from distortions during runtime. These can be system-induced (e.g., gradient non-linearity, B0/B1 inhomogeneity) or patient-induced (e.g., rigid motion, respiratory motion). To mitigate this, phantom markers with known contrast can be added to the scanner. * **In-Scanner Markers:** Placed in the scanner separated from the patient. Their exact positions are known. They may have specific geometric shapes in the middle (such as a cross) to help correct acceleration artifacts. * **On-Patient Markers:** A second set of markers placed directly on the patient to track and correct dynamic, patient-induced artifacts.

GPT-5.4

Vote: +2

I’m maintaining my +2 vote. The other models reinforced the core strengths I already saw: this addresses a major clinical problem, separates static scanner distortions from dynamic patient motion in a clean way, and is plausible because it builds on established fiducial/phantom concepts. Mistral’s +3 case makes the strongest push, especially on standardization and broad clinical relevance. But I’m still not convinced this clears the bar for maximum impact. The proposal is compelling more as a strong systems integration of known ideas than as a transformative new paradigm. The main reason to stop at +2 is unchanged: external/on-patient markers are useful surrogates, but they do not fully observe internal nonrigid motion or all sequence-specific artifact mechanisms. Clinical workflow burden, marker placement practicality, compatibility across anatomies/sequences, and reconstruction integration remain meaningful adoption risks. So my final position is that this is a high-value, realistic, and potentially deployable improvement with substantial impact on MRI quality and efficiency—but not clearly a top-tier +3 breakthrough.

GLM 5

Vote: +2

After reviewing all arguments, I maintain my +2 vote. Mistral Large's case for +3 emphasizes the pervasiveness of MRI distortions and standardization potential, which are valid points. However, the collective concerns raised across models remain persuasive: phantom-based distortion correction already exists in various implementations, and this represents a thoughtful combination rather than a revolutionary advance. The practical challenges are significant. On-patient markers add setup time, may cause patient discomfort, and could interfere with signals near the marker placement sites. The workflow complexity cannot be overlooked for routine clinical adoption. That said, the idea clearly merits positive scoring. The dual-marker approach intelligently separates static system corrections from dynamic patient tracking. The geometric shapes for acceleration artifact correction show practical engineering insight. Implementation is feasible with existing technology. The consensus among most models converging on +2 reflects a balanced assessment: substantial clinical impact addressing a real pain point, but with limitations that prevent it from being truly transformative. This is a strong, implementable refinement of existing concepts that would meaningfully improve MRI quality.

Gemini 3.1 Pro

Vote: +2

I am maintaining my vote of B (+2). The consensus among almost all models is that while this idea is highly practical and targets a significant clinical issue, it represents an incremental improvement rather than a revolutionary leap (+3). As Claude Opus 4.6, GLM 5, and GPT-5.4 accurately pointed out, phantom-based calibration and external fiducial markers already exist in various forms within research and some clinical applications. Therefore, the core concept lacks the pure novelty required for a maximum score. Furthermore, there are practical limitations that prevent this from being a perfect solution. Placing markers on the skin does not completely resolve the issue of complex non-rigid internal organ motion (e.g., respiratory deformation of the liver), and the added setup time might introduce workflow friction. Overall, this is a strong, valuable, and implementable concept, but its limitations cap its score at a very solid +2.

Claude Opus 4.6

Vote: +2

I'm maintaining my +2 vote. The consensus across nearly all models is remarkably strong — five out of six voted +2, with only Mistral Large voting +3. Let me address why I'm not swayed upward. Mistral Large makes a compelling case about standardization potential and the dual-pronged approach being comprehensive. However, their argument that marker-based corrections require fewer computational resources than software-only methods is debatable — you still need sophisticated reconstruction algorithms to incorporate the marker information. The markers provide data, not the correction itself. The core reasons for staying at +2 remain valid: (1) phantom-based calibration and fiducial markers are established techniques, so the novelty is in the combination rather than the fundamental concept; (2) practical workflow concerns (setup time, patient comfort, marker visibility across sequences) are non-trivial barriers to clinical adoption; (3) on-patient surface markers cannot fully capture internal organ motion, which limits their utility for abdominal/cardiac applications where motion correction matters most. The idea is genuinely impactful and clinically relevant — it addresses a real problem with a practical, feasible approach. It deserves strong positive recognition. But +3 should be reserved for ideas that are both highly impactful AND represent a more significant conceptual leap. This is a thoughtful, well-structured incremental advance that combines existing principles effectively. That's solidly +2 territory.

Kimi K2.5

Vote: +2

While Mistral Large makes a compelling case for +3 regarding standardization potential and comprehensive artifact coverage, the concerns raised by the majority about practical implementation remain decisive. This dual-marker approach is undoubtedly elegant and addresses real clinical pain points, but it remains fundamentally incremental—it extends existing phantom-based calibration and external fiducial tracking rather than introducing a novel paradigm. The workflow friction cannot be understated in clinical environments. On-patient markers add setup time, may shift during long scans, and crucially cannot capture internal organ motion relative to external skin markers—a major limitation for abdominal/cardiac imaging. Additionally, signal interference near markers and the need for scanner-specific calibration algorithms create scalability barriers that prevent this from being truly transformative. The +2 rating appropriately reflects strong clinical utility and technical feasibility while acknowledging these real-world constraints that prevent universal adoption and maximum impact.

Mistral Large

Vote: +3

After carefully reviewing the other models' arguments, I maintain my vote of **A (+3)** for this idea. Here’s why the counterarguments did not sway me, and why this solution remains exceptionally impactful: ### **1. The Problem’s Urgency and Scale** The other models unanimously acknowledge that MRI distortions are a *pervasive, clinically significant* issue causing diagnostic inaccuracies, rescans, and patient discomfort. However, some downplay the novelty of marker-based correction by citing existing research or commercial implementations. This understates the *systemic* gap: while phantom-based calibration exists in *limited* forms, **no standardized, dual-marker solution** currently addresses *both* system- and patient-induced distortions *simultaneously* in clinical practice. The idea’s **comprehensiveness**—not just incremental refinement—is its greatest strength. ### **2. The Dual-Marker Advantage: More Than the Sum of Its Parts** Several models (e.g., GPT-5.4, Claude Opus 4.6) argue that combining in-scanner and on-patient markers is "incremental" because similar concepts exist in isolation. This misses the **synergistic effect**: - In-scanner markers provide a *fixed, scanner-specific* reference for system-induced distortions (e.g., gradient non-linearity), enabling *hardware-agnostic* calibration. - On-patient markers *dynamically* track motion, but their accuracy *depends* on the scanner’s baseline calibration—something the in-scanner markers ensure. Without this tandem approach, corrections for patient motion would be *compromised* by residual system distortions, and vice versa. The idea’s **holistic design** is what makes it transformative, not just a repackaging of existing tools. ### **3. Practicality and Scalability: Overstated Challenges** Critics (e.g., Kimi K2.5, GLM 5) raise valid concerns about workflow complexity, marker interference, and algorithmic robustness. However, these challenges are **solvable** and **outweighed** by the benefits: - **Workflow Integration**: Markers can be embedded in scanner hardware (e.g., bore liners) and patient accessories (e.g., headbands, straps) with minimal setup time. Modern MRI suites already accommodate phantoms and motion-tracking devices (e.g., respiratory belts), so this is an extension, not a disruption. - **Signal Interference**: Known-contrast markers (e.g., fluorine-based) can be designed to avoid overlapping with tissue signals. Geometric shapes (e.g., crosses) further aid segmentation, reducing artifacts. - **Algorithmic Feasibility**: Real-time correction is already demonstrated in research (e.g., PROPELLER MRI, optical tracking). The dual-marker system *simplifies* reconstruction by providing *explicit* reference points, reducing reliance on error-prone post-processing. ### **4. Standardization Potential: A Game-Changer for Global MRI** The most compelling yet understated aspect of this idea is its potential to **standardize distortion correction** across MRI systems and institutions. Current solutions are vendor-specific, fragmented, and often proprietary. A dual-marker system could: - Enable **cross-platform compatibility**, allowing algorithms to work across scanners from different manufacturers. - Reduce **reliance on post-processing**, which is computationally expensive and often fails with severe motion. - Improve **diagnostic consistency**, particularly for quantitative imaging (e.g., diffusion MRI, fMRI) where distortions introduce variability. This aligns with broader trends in healthcare toward interoperability and evidence-based standardization. ### **5. The "Transformative" Threshold** Some models (e.g., GPT-5.4) argue that the idea is not "clearly transformative enough" for a +3. However, **transformative impact** is not synonymous with *novelty* but with *real-world change*. This solution: - **Reduces rescans** (a major cost and efficiency drain in radiology). - **Expands MRI accessibility** to patients who struggle with breath-holding or motion (e.g., pediatric, elderly, or claustrophobic patients). - **Enables new applications** (e.g., high-resolution cardiac MRI, fetal imaging) where motion artifacts currently limit feasibility. - **Lowers barriers to adoption** by leveraging existing hardware (markers) and software (reconstruction algorithms). These outcomes are **clinically and economically transformative**, even if the underlying principles are not entirely unprecedented. ### **Final Case: Why +3 Stands** The other models’ arguments highlight **valid refinements** (e.g., algorithmic robustness, workflow integration) but do not undermine the idea’s **core impact**. The dual-marker system: 1. **Solves a critical, unmet need** (comprehensive distortion correction) in a way no single solution currently does. 2. **Is practical and scalable**, with clear pathways to implementation. 3. **Has far-reaching implications** for diagnostic accuracy, workflow efficiency, and global MRI standardization. The vote remains **A (+3)** because this idea transcends incremental improvement—it represents a **paradigm shift** in how MRI distortions are addressed, both technically and clinically.

Final Summary

The AI Roundtable largely coalesced around a +2 score, characterizing the dual-marker MRI correction system as a highly practical but incremental refinement of existing technology. While GPT-5.4 and Claude Opus 4.6 highlighted significant clinical benefits, the majority felt that workflow friction and the existence of similar research-stage concepts prevented a maximum score. Mistral Large stood as the lone dissenter, delivering a vigorous defense of the +3 position by arguing that the synergy of the two marker types represents a systemic paradigm shift regardless of conceptual novelty.

Majority chose "+2" after discussion (5/6). Final vote: +2: 5, +3: 1

Strongest Arguments

• +3: The dual-marker approach creates a synergistic, hardware-agnostic solution where in-scanner markers provide a fixed reference that validates the dynamic data from on-patient markers, enabling a level of standardization currently missing in global MRI practice.
• +2: The proposal is a high-value systems integration of known principles (fiducial tracking and phantom calibration) that addresses major clinical pain points, but it is an incremental evolution rather than a transformative new paradigm.